The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The prescribing information for Qelbree (viloxazine extended-release capsules) has been updated with new pharmacodynamic and lactation data.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback